ERBB2 and neoplasm: Treatment with HER2 × CD3 BsAb having a low-affinity arm led to a higher accumulation in HER2+ tumor tissues and a lower distribution to T-cell rich secondary lymphoid organs such as the spleen and lymph nodes [65].